There is considerable interest in developing inexpensive, nonintrusive diagnostic tests for Alzheimer's disease (AD), in the hope these tests will facilitate early diagnosis and support design of effective treatments. While tests based on blood-borne biomarkers such as microRNAs have shown promise, work to date indicates these tests often do not generalize well: diagnostic models derived for one patient group are not accurate when applied to a new cohort. This paper presents a novel ensemble-based transfer learning methodology which induces models that provide accurate diagnoses across distinct patient groups without retraining. The algorithm combines information from supervised ensemble learning and unsupervised ensemble clustering to enable robust transfer learning. The efficacy of the approach is illustrated through a case study involving microRNA-based AD diagnosis. In this test, we use our algorithm to learn a diagnostic model on data from one patient group and then apply the model to a different target group, obtaining diagnostic accuracy which actually exceeds that of a state-of-the-art model trained directly on the target group.

Download full-text PDF

Source
http://dx.doi.org/10.1109/EMBC.2017.8037513DOI Listing

Publication Analysis

Top Keywords

transfer learning
12
alzheimer's disease
8
patient group
8
target group
8
ensemble transfer
4
learning
4
learning alzheimer's
4
disease diagnosis
4
diagnosis considerable
4
considerable interest
4

Similar Publications

Need For A Strategic Approach To Knowledge Transfer And Exchange: Late-phase clinical trials and systematic reviews find results that have the potential to improve health outcomes for people. However, there are often delays in these results influencing clinical practice. We developed a knowledge transfer and exchange strategy to support research teams, aiming to identify activities along the research process to maximise and accelerate the research impact.

View Article and Find Full Text PDF

Background: Accurate classification of host phenotypes from microbiome data is crucial for advancing microbiome-based therapies, with machine learning offering effective solutions. However, the complexity of the gut microbiome, data sparsity, compositionality, and population-specificity present significant challenges. Microbiome data transformations can alleviate some of the aforementioned challenges, but their usage in machine learning tasks has largely been unexplored.

View Article and Find Full Text PDF

The advancements in cardiovascular imaging over the past two decades have been significant. The miniaturization of ultrasound devices has greatly contributed to their widespread adoption in operating rooms and intensive care units. The integration of AI-enabled tools has further transformed the field by simplifying echocardiographic evaluations and enhancing the reproducibility of hemodynamic measurements, even for less experienced operators.

View Article and Find Full Text PDF

A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma.

Biomark Res

January 2025

Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361003, P.R. China.

Background: Disease progression within 24 months (POD24) significantly impacts overall survival (OS) in patients with follicular lymphoma (FL). This study aimed to develop a robust predictive model, FLIPI-C, using a machine learning approach to identify FL patients at high risk of POD24.

Methods: A cohort of 1,938 FL patients (FL1-3a) from seventeen centers nationwide in China was randomly divided into training and internal validation sets (2:1 ratio).

View Article and Find Full Text PDF

CYP3A5 promotes glioblastoma stemness and chemoresistance through fine-tuning NAD/NADH ratio.

J Exp Clin Cancer Res

January 2025

School of Medicine, Chinese PLA General Hospital, Nankai University, Beijing, China.

Background: Glioblastoma multiforme (GBM) exhibits a cellular hierarchy with a subpopulation of stem-like cells known as glioblastoma stem cells (GSCs) that drive tumor growth and contribute to treatment resistance. NAD(H) emerges as a crucial factor influencing GSC maintenance through its involvement in diverse biological processes, including mitochondrial fitness and DNA damage repair. However, how GSCs leverage metabolic adaptation to obtain survival advantage remains elusive.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!